BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919 AND Treatment
30 results:

  • 1. Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression.
    Ullah MA; Moin AT; Nipa JF; Islam NN; Johora FT; Chowdhury RH; Islam S
    J Leukoc Biol; 2024 Mar; 115(4):723-737. PubMed ID: 38323674
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression.
    Birdwell CE; Fiskus W; Kadia TM; Mill CP; Sasaki K; Daver N; DiNardo CD; Pemmaraju N; Borthakur G; Davis JA; Das K; Sharma S; Horrigan S; Ruan X; Su X; Khoury JD; Kantarjian H; Bhalla KN
    Leukemia; 2024 Mar; 38(3):545-556. PubMed ID: 38086946
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. FOXO1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells.
    Pintor S; Lopez A; Flores D; Lozoya B; Soti B; Pokhrel R; Negrete J; Persans MW; Gilkerson R; Gunn B; Keniry M
    FEBS Open Bio; 2023 Nov; 13(11):2108-2123. PubMed ID: 37584250
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic leukemia.
    Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
    Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The mRNA Expression of
    Lak ER; Tamaddon G; Ramzi M; Ranjbaran R; Abedi E; Sharifzadeh S
    Cardiovasc Hematol Agents Med Chem; 2023; 21(1):67-76. PubMed ID: 35993473
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes.
    Xu R; Huang X; Li C; Deng C; Li M; Wu P; Geng S; Lai P; Lu Z; Weng J; Du X
    Br J Haematol; 2021 Jun; 193(5):928-940. PubMed ID: 33959953
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deciphering the role of Wnt signaling in acute myeloid leukemia prognosis: how alterations in DNA methylation come into play in patients' prognosis.
    Cardona-Echeverry A; Prada-Arismendy J
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3097-3109. PubMed ID: 32980885
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Sequential development of mantle cell lymphoma following chronic lymphocytic leukemia].
    Saga T; Ishihara T; Ito M; Kano S; Kanagawa M
    Rinsho Ketsueki; 2020; 61(3):251-256. PubMed ID: 32224586
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Differences in expression and function of lef1 isoforms in normal versus leukemic hematopoiesis.
    Feder K; Edmaier-Schröger K; Rawat VPS; Kirsten N; Metzeler K; Kraus JM; Döhner K; Döhner H; Kestler HA; Feuring-Buske M; Buske C
    Leukemia; 2020 Apr; 34(4):1027-1037. PubMed ID: 31758089
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Wnt Signalling in Acute Myeloid Leukaemia.
    Gruszka AM; Valli D; Alcalay M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31703382
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Effect of Quercetin on Wnt/β-Catenin Signal Pathway of K562 and K562R Cells].
    Li W; Zhao Y; Qiu L; Ma J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1409-1415. PubMed ID: 31607291
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1.
    Li F; He B; Ma X; Yu S; Bhave RR; Lentz SR; Tan K; Guzman ML; Zhao C; Xue HH
    Cell Stem Cell; 2017 Sep; 21(3):359-373.e5. PubMed ID: 28844837
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
    Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
    Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Activation of EVI1 transcription by the lef1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. High lef1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
    Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
    Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.
    Ghamlouch H; Darwiche W; Hodroge A; Ouled-Haddou H; Dupont S; Singh AR; Guignant C; Trudel S; Royer B; Gubler B; Marolleau JP
    Oncotarget; 2015 Jul; 6(21):18484-503. PubMed ID: 26050196
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Overexpression of lymphoid enhancer-binding factor-1 (lef1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
    Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
    Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset.
    Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
    Leuk Lymphoma; 2015 Feb; 56(2):480-91. PubMed ID: 24844359
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia.
    Fu Y; Zhu H; Wu W; Xu J; Chen T; Xu B; Qian S; Li J; Liu P
    Leuk Lymphoma; 2014 Feb; 55(2):371-7. PubMed ID: 23713453
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
    Nishida Y; Takeuchi K; Tsuda K; Ugai T; Sugihara H; Yamakura M; Takeuchi M; Matsue K
    Eur J Haematol; 2013 Aug; 91(2):179-82. PubMed ID: 23581835
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.